Clinical Trial Details
EORTC-30873
Back to Clinical Trials Database
A randomized phase III study of BEP (bleomycin, etoposide (VP-16), cisplatin) versus VIP (VP-16, ifosfamide, cisplatin) in intermediate risk patients with disseminated non-seminomatous testicular cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Sep-1987 Date Step1 close: 15-Jun-1990 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 240 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
